Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   


neurodegeneration2 - hypertension3 - artery-clogging process1 - harvard medical school1 - microhemmorhage1 - journal of alzheimer's disease2 - prevent dementia4 - synthetic tau fibrils1 - amnesia1 - mid-stage of alzheimer's1 - csf1 - cognitive health3 - professor lewy1 - positron emission tomography3 - rheumatoid arthritis1 - vesanic dementia2 - alzheimer's changes2 - epidemiology1 - signs of alzheimer's1 - degree of dementia1 - inherited condition1 - repair damaged nerve tissue1 - myxoedema1 - vascular risk factors2 - tau proteins1 - memory decline2 - moderate parkinson's disease1 - dantrolene1 - cognitive symptoms1 - high cholesterol1 -